Curaleaf

Multistate cannabis operator Curaleaf will pay $100,000 to settle a class-action lawsuit related to a 2021 incident wherein the company sold drops labeled for CBD but which actually contained THC.

Seven cannabis companies received 54 citations from the New Jersey Cannabis Regulatory Commission from January 2020 to April 2022 over allegations including failing to register patients in the medical cannabis registry, security violations, and mold.

Tilray CEO Irwin Simon said the growing U.S. cannabis industry will represent a $100 billion opportunity by the time widespread legalization is achieved.

Curaleaf pulled thousands of cannabis products from New York dispensary shelves after the company switched to a new and still unapproved method of product potency labeling.

Multistate cannabis firm Curaleaf did not offer Juneteenth holiday pay for its unionized employees but did for non-unionized employees.

The Portland attorney who previously settled 10 lawsuits against Curaleaf for its THC/CBD product mix-up is now seeking $200 per customer regardless of whether they were made ill by the products.

New Jersey has approved seven medical cannabis companies to expand their operations into the adult-use market.

Curaleaf has settled 10 lawsuits related to its mix-up last year of THC and CBD tinctures at a Portland, Oregon facility. Additional cases, including a wrongful death suit, are still pending.

The tenth lawsuit against Curaleaf for a CBD/THC label mix-up involves an alleged wrongful death claim.

Curaleaf is partnering with Southern Glazer’s Wine & Spirits, the world’s largest alcohol distributor, to distribute its Hemp and Select CBD products.

Curaleaf has agreed to acquire Tryke Companies, which owns and operates two retail dispensaries in Arizona and four in Nevada, for $286 million in a cash and stock deal.

Cannabis firms Ayr Wellness Inc., Curaleaf Holdings Inc., and The Parent Company each announced acquisition deals on Monday for $80 million, $67 million, and $65.2 million, respectively.

An Idaho man is suing Curaleaf over a product mixup that resulted in the company’s Select-brand CBD drops being recalled last week for containing THC.

The Oregon Liquor and Cannabis Commission last week recalled Cura’s Select brand tincture products after the company reportedly mixed up a line of THC and CBD products.

Curaleaf Holdings is set to acquire EMMAC Life Sciences Ltd., Europe’s largest vertically integrated cannabis company, for approximately $286 million.

Anticipating accelerated cannabis reforms around the country, Curaleaf Holdings yesterday announced an offering of 16.5 million subordinate voting shares at C$16.70 per share.

Curaleaf reported pro forma revenue of $215.3 million for the third quarter of the year and a year-to-date managed revenue of nearly $420 million.

Curaleaf has successfully completed its acquisition of Grassroots to become the largest vertically-integrated cannabis operator in the country.

Curaleaf announced it is expanding its Select vaporizers brand into four new state markets: Maine, Massachusetts, Ohio, and Florida.

Officials in Ware, Massachusetts have approved a bid by Curaleaf to host a medical cannabis dispensary inside of its store that has been licensed for adult-use sales.

Curaleaf Holdings announced it is set to acquire Colorado-based edibles company BlueKudu for an undisclosed amount.

Massachusetts’ Curaleaf Holdings Inc. has completed its acquisition of Oregon’s Cura Partners for a bit less than $400 million; the deal includes 53 dispensaries, wholesale business, and the Select brand.

The world’s first billionaire from the legal cannabis industry is reportedly Boris Jordan, chairman for Curaleaf.

Curaleaf Holdings Inc. will acquire GR Companies Inc. in an $875 million cash and stock deal; the sale will create the largest cannabis company in the world by revenue, the company announced.